Triple

T15921517
Position Surface form Disambiguated ID Type / Status
Subject Certificates of Suitability to the monographs of the European Pharmacopoeia E386103 entity
Predicate basedOn P98 FINISHED
Object European Pharmacopoeia E387634 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Pharmacopoeia | Statement: [Certificates of Suitability to the monographs of the European Pharmacopoeia, basedOn, European Pharmacopoeia]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: European Pharmacopoeia
Context triple: [Certificates of Suitability to the monographs of the European Pharmacopoeia, basedOn, European Pharmacopoeia]
  • A. European Pharmacopoeia chosen
    The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
  • B. Certificates of Suitability to the monographs of the European Pharmacopoeia
    Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
  • C. European Union pharmaceutical legislation
    European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
  • D. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • E. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d86da686e4819097cbf3b1fc2d881d completed April 10, 2026, 3:25 a.m.
NER Named-entity recognition batch_69e156825b1881908477ec93cc7b5f02 completed April 16, 2026, 9:37 p.m.
NED1 Entity disambiguation (via context triple) batch_69ffc3bd67f48190aee4f892206d9326 completed May 9, 2026, 11:31 p.m.
Created at: April 10, 2026, 4:52 a.m.